AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00305656
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
NIH
Sponsor class
Conditions
Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor
Interventions
DRUG:
cediranib maleate
Sponsor
National Cancer Institute (NCI)